These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15298228)

  • 1. The future incidence of leprosy: a scenario analysis.
    Meima A; Smith WC; van Oortmarssen GJ; Richardus JH; Habbema JD
    Bull World Health Organ; 2004 May; 82(5):373-80. PubMed ID: 15298228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of leprosy control on the transmission of M. leprae: is elimination being attained?
    Richardus JH; Habbema JD
    Lepr Rev; 2007 Dec; 78(4):330-7. PubMed ID: 18309706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
    Janaszek W
    Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long lasting BCG protection against leprosy.
    Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
    Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in leprosy case detection worldwide since 1985.
    Meima A; Richardus JH; Habbema JD
    Lepr Rev; 2004 Mar; 75(1):19-33. PubMed ID: 15072123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIMLEP: a simulation model for leprosy transmission and control.
    Meima A; Gupte MD; van Oortmarssen GJ; Habbema JD
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):215-36. PubMed ID: 10575401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP; Ambadekar NN; Thakur A
    Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of an economic model to the study of leprosy control costs.
    Lechat MF; Vellut C; Misson CB; Misson JY
    Int J Lepr Other Mycobact Dis; 1978; 46(1):14-24. PubMed ID: 565752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leprosy New Case Detection Trends and the Future Effect of Preventive Interventions in Pará State, Brazil: A Modelling Study.
    de Matos HJ; Blok DJ; de Vlas SJ; Richardus JH
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004507. PubMed ID: 26938738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
    Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
    Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in new case-detection leprosy in Bihar, India.
    Vijayakumaran P; Prasad B; Krishnamurthy P
    Indian J Lepr; 2006; 78(2):145-51. PubMed ID: 16927849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in detection of new leprosy cases at two centres in Himachal Pradesh, India: a ten-year study.
    Mahajan VK; Sharma NL; Rana P; Sood N
    Indian J Lepr; 2003; 75(1):17-24. PubMed ID: 15253391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dermatologists in leprosy elimination and post-elimination era.
    Nery JA; Lehman LF; Schreuder PA
    Lepr Rev; 2007 Mar; 78(1):41-2. PubMed ID: 17518089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLEP--current situation and strategy during the 11th plan period (2007-2012).
    Dhillon GP
    J Indian Med Assoc; 2006 Dec; 104(12):671-2. PubMed ID: 17474280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
    Richardus JH; Oskam L
    Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards the elimination of leprosy in Nigeria: a review of the role of policy implementation and operational factors.
    Ogbeiwi OI
    Lepr Rev; 2005 Mar; 76(1):65-76. PubMed ID: 15881037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study.
    Fischer EA; de Vlas SJ; Habbema JD; Richardus JH
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1330. PubMed ID: 21949895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.